The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis
- PMID: 3097148
The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis
Abstract
Mice infected i.v. with the virulent Erdman strain of Mycobacterium tuberculosis exhibited three distinct phases of infection within the spleen. These consisted of a primary phase, characterized by the progressive growth of the organism; a secondary phase, in which the viable organism was progressively eliminated; and a tertiary phase, characterized by a chronic or slowly recrudescing disease state. Passive transfer experiments, in which T cell-enriched spleen cells from immune donors were infused into T cell-deficient recipients and were measured for their capacity to adoptively protect these mice from challenge with M. tuberculosis, provided evidence that at least three separate populations of protective T cells were acquired in response to the infection within the time frame of the experiments. These populations of T cells could be distinguished in that they differed in their expression of the L3T4 and Lyt-2 cell surface molecules, in terms of their kinetic profiles of emergence and loss, and (c) in terms of their susceptibility to cyclophosphamide. The results may suggest that different populations of protective T cells can be generated at different times during the infection as various classes of antigens (for example, metabolic or structural antigens) become available for presentation by host macrophages. It is hypothesized, furthermore, that the kinetics of emergence and loss of these various populations may reflect switching in the mode of immunity being expressed, particularly during the chronic phase of the infection, from that of a state of active immunity to one of immunologic memory.
Similar articles
-
Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection.J Immunol. 1988 May 15;140(10):3589-93. J Immunol. 1988. PMID: 3129497
-
Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice. Assessment by elimination of T cell subsets in vivo.J Immunol. 1987 Sep 15;139(6):2032-7. J Immunol. 1987. PMID: 3114383
-
Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes.J Immunol. 1987 Jun 15;138(12):4414-8. J Immunol. 1987. PMID: 3495592
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
Mechanisms of immunity in tuberculosis.Pathobiol Annu. 1979;9:137-62. Pathobiol Annu. 1979. PMID: 113763 Review. No abstract available.
Cited by
-
Induction and expression of protective T cells during Mycobacterium avium infections in mice.Clin Exp Immunol. 1992 Mar;87(3):379-85. doi: 10.1111/j.1365-2249.1992.tb03006.x. Clin Exp Immunol. 1992. PMID: 1544223 Free PMC article.
-
In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosis.Infect Immun. 1987 Sep;55(9):2223-9. doi: 10.1128/iai.55.9.2223-2229.1987. Infect Immun. 1987. PMID: 3114149 Free PMC article.
-
Kinetics of accumulation of gamma delta receptor-bearing T lymphocytes in mice infected with live mycobacteria.Infect Immun. 1991 Nov;59(11):4263-5. doi: 10.1128/iai.59.11.4263-4265.1991. Infect Immun. 1991. PMID: 1834574 Free PMC article.
-
The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model.Infect Immun. 2003 Apr;71(4):1929-37. doi: 10.1128/IAI.71.4.1929-1937.2003. Infect Immun. 2003. PMID: 12654810 Free PMC article.
-
Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor.Infect Immun. 1992 Mar;60(3):1249-53. doi: 10.1128/iai.60.3.1249-1253.1992. Infect Immun. 1992. PMID: 1541542 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical